xinbang phar.(SZ:002390) Zheng Quan Ri Bao·2025-09-03 10:15Core Viewpoint - The company is focusing on strengthening partnerships in the traditional Chinese medicine (TCM) sector and accelerating the development of new markets, while also enhancing its health product offerings to create new growth points [2]. Group 1: Traditional Chinese Medicine - The company's subsidiary, Guizhou Tongde Pharmaceutical Co., Ltd., will deepen cooperation with major clients in the TCM sector [2]. - The company plans to leverage the national collection of TCM decoction pieces to expedite the development of new markets [2]. Group 2: Health Products - The company aims to accelerate product development in the health product segment, optimizing existing products based on market demand and feedback [2]. - There is an intention to increase resource investment in health products to cultivate this business as a new growth point for the company [2]. - Currently, the company has no plans to consider exporting TCM decoction pieces or health products [2].